Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes Mellitus, Type 2
- Sponsor
- Scripps Whittier Diabetes Institute
- Enrollment
- 310
- Locations
- 2
- Primary Endpoint
- Glycosylated Hemoglobin (HbA1c) 6 Months After Enrollment
- Status
- Completed
- Last Updated
- 10 months ago
Overview
Brief Summary
This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that is tailored to individuals' needs and behavioral progress, in improving diabetes clinical control, adherence, and patient-provider communication in Hispanics - an at-risk, understudied population that experiences disparities in diabetes prevalence and outcomes. These striking disparities in the growing and aging US Hispanic population have taxed the US healthcare system, while significantly reducing quantity and quality of life for millions of individuals. By offering an innovative, scalable, and sustainable approach that seamlessly integrates several mHealth technologies into existing primary care team processes to improve the health of Hispanics (and eventually, other at-risk, underserved groups), DD-Me has strong potential to significantly impact public health.
Detailed Description
Individuals of low socioeconomic (SES) and ethnic minority status, including Hispanics, the largest U.S. ethnic minority group, are disproportionately affected by diabetes. Poor healthcare access and cultural barriers prevent optimal care, adherence, and clinical benefit, thus placing Hispanics at high risk for costly diabetes complications. The investigators' established academic-healthcare-community partnership has unique experience in developing and testing innovative, cost-effective, and sustainable chronic care interventions to reduce disparities and improve health in underserved communities. The investigators recently developed Dulce Digital (i.e., "one-size-fits-all" educational text messages, with nurse monitoring of patient-transmitted blood glucose values), which improved glycemic control across 6 months, relative to usual care in a recent randomized controlled trial (RCT) of N=126 Hispanic patients with poorly controlled type 2 diabetes (T2DM). The process evaluation for this trial indicated that Dulce Digital was both feasible and acceptable from patient and provider perspectives; however, patients expressed a preference for a more individualized intervention, and providers requested an even greater focus on health behavior change. Thus, the proposed RCT will examine the comparative effectiveness of Dulce Digital versus "Dulce Digital-Me" (DD-Me) in N=414 Hispanic adults of low SES with poorly controlled T2DM from Neighborhood Healthcare, a San Diego Federally-Qualified Health Center. Guided by patient and provider feedback, DD-Me includes Dulce Digital components plus personalized goal-setting and feedback that is responsive to the individual's needs and preferences. The DD-Me adaptive feedback component will be informed by the Resources and Support for Self-Management Model and Operant Conditioning Theory, and based on the individual's progress on intermediate behavioral targets (i.e., medication adherence assessed by wireless sensor; brief mobile phone-based assessments of diet, physical activity, stress). Feedback will be delivered via algorithm-driven automated messaging in 50% of DD-Me participants and by the care team medical assistant in the remaining half to determine the feasibility and acceptability (given the purported cultural relevance of interpersonal relationships in the Hispanic culture), and the comparative effectiveness and cost of each delivery method. Changes in indicators of diabetes clinical control \[i.e., glycosylated hemoglobin (HbA1c) low density lipoprotein cholesterol (LDL-C), systolic blood pressure (SBP)\], patient-provider communication, and patient adherence (i.e., to medication and other diabetes self-management behaviors) will be evaluated across twelve months. Thorough process and cost-effectiveness analyses will evaluate the scalability and sustainability potential of DD-Me. This comparative evaluation of two mHealth approaches will elucidate how technology can be integrated most effectively and efficiently within existing nurse-led chronic care approaches to meet the complex needs of underserved individuals with poorly controlled T2DM.
Investigators
Athena Philis-Tsimikas
Corporate Vice President
Scripps Whittier Diabetes Institute
Eligibility Criteria
Inclusion Criteria
- •Self-identified Hispanic/Latino
- •18 years or older
- •Registered patient of a Neighborhood Healthcare Clinic
- •Diagnosed with T2DM (Type 2 Diabetes Mellitus)
- •HbA1c ≥ 8.0% and/or SBP ≥ 160 mmHg, and/or LDL-C ≥ 100 mg/dL in the last 30 days
Exclusion Criteria
- •Severe illness precluding regular clinic visits
- •Pregnant or lactating
- •Type 1 or gestational diabetes
- •Lack of minimal literacy
- •Plans to relocate
- •Severe auditory or visual problems
- •Primary language other than Spanish or English
- •Unwilling to carry a mobile phone
Outcomes
Primary Outcomes
Glycosylated Hemoglobin (HbA1c) 6 Months After Enrollment
Time Frame: 6 months from baseline
Glycosylated Hemoglobin (HbA1c) six months after enrollment
Glycosylated Hemoglobin (HbA1c) 12 Months After Enrollment
Time Frame: 12 months from baseline
Glycosylated Hemoglobin (HbA1c) twelve months after enrollment
Low-density Lipoprotein-cholesterol (LDL-C); 6 Months After Enrollment
Time Frame: 6 months from baseline
Low-density lipoprotein-cholesterol (LDL-C); six months after enrollment
Low-density Lipoprotein-cholesterol (LDL-C); 12 Months After Enrollment
Time Frame: 12 months from baseline
Low-density lipoprotein-cholesterol (LDL-C); twelve months after enrollment
Systolic Blood Pressure (SBP); 6 Months From Enrollment
Time Frame: 6 months from baseline
Systolic blood pressure (SBP); six months from enrollment
Systolic Blood Pressure (SBP); 12 Months From Enrollment
Time Frame: 12 months from baseline
Systolic blood pressure (SBP); twelve months from enrollment
Secondary Outcomes
- Patient-Provider Communication; 6 Months From Enrollment(6 months from baseline)
- Patient-Provider Communication; 12 Months From Enrollment(12 months from baseline)
- Patient Blood Glucose Monitoring; 6 Months From Enrollment(6 months from baseline)
- Patient Blood Glucose Monitoring; 12 Months From Enrollment(12 months from baseline)
- Participated in Aerobic Exercise; 6 Months From Enrollment(6 months from baseline)
- Participated in Aerobic Exercise; 12 Months From Enrollment(12 months from baseline)
- Participated in Strength Exercise; 6 Months From Enrollment(6 months from baseline)
- Participated in Strength Exercise; 12 Months From Enrollment(12 months from baseline)
- Participated in Flexibility Exercise; 6 Months From Enrollment(6 months from baseline)
- Participated in Flexibility Exercise; 12 Months From Enrollment(12 months from baseline)
- Healthy Eating Behaviors; 6 Months From Enrollment(6 months from baseline)
- Healthy Eating Behaviors; 12 Months From Enrollment(12 months from baseline)
- Diabetes Distress; 6 Months From Enrollment(6 months from baseline)
- Diabetes Distress; 12 Months From Enrollment(12 months from baseline)
- Adherence to Refills and Medications Scale (ARMS) - Patient-reported Outcome; 6 Months From Enrollment(6 months from baseline)
- Adherence to Refills and Medications Scale (ARMS) - Patient-reported Outcome; 12 Months From Enrollment(12 months from baseline)